ABSTRACT The lipophilic cation triphenylmethylphosphonium (Ph3MeP+), which is widely used as a sensor for membrane potential with cells, organelles, and membrane vesicles, is shown also to accumulate in membranes rich in nicotinic acetylcholine receptor in a voltage-independent way. Evidence is presented that Ph3MeP+ in this sytem is bound to a cation-binding site of the ion channel that is part ofthe acetylcholine receptor complex. Binding is stimulated by cholinergic effectors (Kd = 13 ,gM in the absence of carbamoylcholine; Kd = 1.5 ,uM in the presence of 10 jLM carbamoylcholine), and this stimulation is blocked by a-bungarotoxin.
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Ph3MeP+ blocks efflux of 'Na from receptor-rich microsacs and appears to compete with the channel ligand phencyclidine for a common binding site. In contrast to the binding of other proven channel ligands, Ph3MeP+-binding is not affected by desensitization.
The lipophilic cation triphenylmethylphosphonium (Ph3MeP+) and the related compound tetraphenylphosphonium are widely used as membrane potential sensors for whole cells (1, 2) , subcellular fractions such as synaptosomes (3) , and membrane vesicles (4) . These cations accumulate into the membrane-enclosed compartment, when a potential (interior negative) is generated across the membrane. Using radioactively labeled ions, it is possible to determine the amount ofions accumulated by a simple filtration assay (5 Hepes at pH 7.4, or K-rich medium, which contains 165 mM KC1, 2 mM CaCl2, 0.1 mM phenylmethylsulfonyl fluoride, and 10 mM Hepes at pH 7.4. Binding is measured at 20-22°C. The filters used (EHWP 02500 Celotate filters, pore width 0.45 ,um, Millipore, Neu-Isenburg) are soaked in Na-rich medium containing bovine serum albumin at 10 mg/ml for at least 2 hr prior to use. Binding reaction is started by 1:10 dilution ofthe membrane suspension in either Na-or K-rich medium containing bovine serum albumin at 1 mg/ml and additional reagents and ligands as described in Results. At the indicated time intervals, the binding reaction is stopped by diluting 100 ,ul of reaction mixture with 3 ml ofice-cold Na-rich medium containing bovine serum albumin at 1 mg/ml followed by rapid filtration. The filters were washed twice with 3 ml of ice-cold Na-rich medium containing bovine serum albumin at 1 mg/ml and radioactivity is measured with 0.2 ml of H20 and 5 ml of Supertron (Kontron, Munchen) in a liquid scintillation counter.
RESULTS
Voltage-Dependent and Carbamoylcholine-Stimulated PH]Ph3MeP+ Accumulation. Receptor-rich membrane fragments incubated overnight in K-rich medium were diluted into Na-rich medium and a K diffusion potential was generated that stimulated Ph3MeP+ accumulation (Fig. 1A) . But (Fig. 1B) . This is in contrast to theoretical predictions, because one would expect the acetylcholine receptor ion channel to be opened by the agonist, the membrane to be depolarized, and accumulation to be inhibited. The stimulating effect of carbamoylcholine could be antagonized by preincubating the acetylcholine receptor-rich membranes with a-bungarotoxin.
[3H]Ph3MeP+ binding is specific-i.e., saturable (see Fig. 4 Membrane suspension was diluted into either K-rich (a) or Na-rich (0) medium. (B) Dilution medium contained 10MM carbamoylcholine.
Membrane suspension was diluted into either K-rich (W) or Na-rich (a) medium. a, Membrane suspension was incubated 10 min at room temperature with 10 ,uM a-bungarotoxin prior to dilution into Na-rich medium.
decamethonium, and d-tubocurarine (Fig. 3B) (Fig. 4) . A probably reflects the existence ofa second, low-affinity, binding site, the nature of which has not yet been investigated.
Ph3MeP+ Blocks 22Na Efflux from Acetylcholine ReceptorRich Membrane Vesicles. A convenient method for measuring acetylcholine receptor function in vitro is monitoring the 22Na efflux after dilution of preloaded acetylcholine receptor-rich membrane vesicles (10) . Efflux can be stimulated by cholinergic agonists-e.g., carbamoylcholine. In the experiment shown in Fig. 5A efflux stimulated by 10 AM carbamoylcholine was slightly reduced by 0.1 mM Ph3MeP+ and was completely blocked by 1.0 mM Ph3MeP+ in the dilution medium.
The blocking effect of Ph3MeP+ on the ion channel could be potentiated by preincubating the receptor-rich vesicles with the lipophilic cation. In this case, efflux stimulation was fully inhibited by 10 AuM Ph3MeP+ (Fig. 5B) , a concentration at which
[3H]acetylcholine binding is not yet blocked.
Ph3MeP+ Is a Competitive Inhibitor of [3H]PCP Binding. To test further the possibility that Ph3MeP+ is an ion channel ligand we investigated the effect ofPh3MeP+ on [3H]PCP binding. PCP is a general anesthetic and hallucinogen and was shown to bind to the ion channel of the acetylcholine receptor complex, thereby blocking ion translocation (11, 12) . Binding of PCP is also stimulated by cholinergic agonists (12) . Specific binding of [3H]PCP either in the absence or in the presence of carbamoylcholine is completely blocked by Ph3MeP+ (Fig. 6 ). Nonspecific binding in this experiment was determined in the presence of 5 mM amantadine, which was previously shown to roc. Nad Acad. Sci. USA 79 (1982) be a channel ligand (13, 14 Fig. 4 ).
DISCUSSION
The ion-translocating part of the receptor ("ion channel" or "ionophore") so far has been investigated predominantly by using radioactively labeled perhydrohistrionicotoxin (H12-HTX) (15) (16) (17) (18) (19) (20) . Just recently, PCP was introduced for the same purpose (11, 12, 21) . There are striking similarities in the binding characteristics ofthese "channel ligands" with those of Ph3MeP+. Binding of all three compounds is stimulated by cholinergic agonists. This effect is inhibited by the antagonist a-bungarotoxin; antagonists alone (d-tubocurarine), however, stimulate binding also but to a lesser degree. Above a certain agonist concentration, stimulation of Ph3MeP+ and H12-HTX binding is decreased. Local anesthetics inhibit binding ofchannel ligands. H12-HTX, PCP, and Ph3MeP+ block the ion channel at concentrations at which there is no effect on binding of cholinergic agonists.
However, there is one important difference between Ph3MeP+ on the one hand and H12-HTX and PCP on the other: stimulation of binding of the latter two drugs is inhibited by desensitization. In fact, for this reason H12-HTX has been proposed as a tool for monitoringdifferent functional states ofthe receptor complex; in contrast, desensitization has no effect on Ph3MeP+ binding. In addition, there are strong indications suggesting differences in the binding sites of the ion channel for H12-HTX and PCP: affinities obtained for various channel drugs (adiphenine, dibucaine, dimethisoquine, piperocaine, procaine, quinacrine, tetracaine, amantadine) are different when determined by inhibition of PCP or H12-HTX binding (12) . Furthermore, affinity of piperocaine for PCP-binding sites is enhanced 10-fold after receptor stimulation, whereas it is reduced by 90% for H12-HTX-binding sites (12, 22) .
We conclude from these observations that channel ligands do not necessarily bind to identical sites, although they appear to bind competitively. Thus we would like to introduce Ph3MeP+ as a channel ligand, the properties of which can be summarized as follows: Ph3MeP+ is a lipophilic cation exhibiting affinity for the ion channel of the acetylcholine receptor complex and blocking it upon binding. Its binding site is coupled with the binding site for the usual cholinergic effectors; binding is stimulated by both receptor activation and binding of antagonists and is not inhibited by desensitization.
-At present we cannot explain the observation that not only the channel-opening agonists but also antagonists stimulate Ph3MeP+ binding. The cation-binding site of the ionophore appears to be exposed by cholinergic effectors in a step preceding agonist-specific opening of the channel.
Recently a report on the effects of lipophilic cations (tetraphenylarsonium, tetraphenylphosphonium, and Ph3MeP+) on motility and other physiological properties of the bacterium Bacillus subtilis has been published (23). The authors found major changes in various parameters, including swimming speed and frequency of tumbling. They concluded from their evidence that lipophilic cations perturb the process of conversion of the protonmotive force into work. Whether this fact can be related to a similar channel blocking activity as described here could well be worth further investigation. At any rate, measurements ofvoltage dependent Ph3MeP+ binding to membrane systems should be interpreted with care.
